Core Viewpoint - On October 28, Bibete experienced a significant stock price increase of 74.41%, with a trading volume of 1.107 billion yuan [1] Financing Summary - On the same day, Bibete recorded a financing purchase amount of 74.9658 million yuan, with a financing repayment of 14.0578 million yuan, resulting in a net financing purchase of 60.908 million yuan [1] - As of October 28, the total financing and securities lending balance for Bibete was 60.908 million yuan, which represents 4.23% of its market capitalization [1] Securities Lending Summary - On October 28, Bibete had no shares repaid or sold in the securities lending market, resulting in a selling amount of 0 yuan [1] - The securities lending balance and remaining shares were both recorded as 0 [1] Company Overview - Bibete Pharmaceutical Co., Ltd. is located in the Science City of Guangzhou, Guangdong Province, and was established on January 19, 2012, with its listing date on October 28, 2025 [1] - The company focuses on the independent research and development of innovative drugs [1] Financial Performance - For the period from January to September 2025, Bibete reported zero revenue and a net loss attributable to shareholders of 107 million yuan [1] - The number of shareholders increased to 48,000, reflecting a 95,870% increase compared to the previous period [1] - The average number of circulating shares per shareholder was 968, with no change from the previous period [1]
必贝特10月28日获融资买入7496.58万元，融资余额6090.80万元